In light of this importance, this systematic review was conducted to pool the scientific evidence available on QOL and its factors associated with it among adult survivors of COVID 19, at different timelines. Therefore, it is necessary and timely to compile global evidence on the QOL of COVID 19 patients following discharge or recovery. In this context, studies on the QOL of COVID 19 patients following discharge or recovery has been grown very rapidly. Of them, SF-36, SF-12, EQ-5D-5L and EQ-5D-3L are most widely used in different settings throughout the world. At least 150 different instruments are available to assess a person’s QOL. QOL is a widely used indicator for assessing and evaluating one’s health and wellbeing. It is important and timely to ascertain the impact of COVID 19 on those affected to assist healthcare professionals and government agencies in providing them with better support in advance. Clinically stable COVID 19 patients can also be presented with depressive symptoms and lower QOL after the recovery. ![]() This has been severely affected to the patient’s quality of life (QOL). Patients experience significantly higher levels of post-traumatic stress symptoms and depression due to the disease’s novelty and the persistence of the symptoms. ![]() Several studies have discovered that some of these manifestations persist in patients even after being discharged or recovered from the disease. Fever, cough, sore throat, dyspnea, myalgia or fatigue are all common clinical manifestations of the disease. Coronavirus disease 2019 (COVID 19) is an infectious disease caused by novel coronavirus (SARS-CoV-2), a member of the family Coronaviridae.
0 Comments
Leave a Reply. |